Toggle Offcanvas
...
 
Immunosuppressive Agents Tenders

Immunosuppressive Agents Tenders

View immunosuppressive agents tenders, RFPs and contracts. Bid on readily available immunosuppressive agents tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for immunosuppressive agents tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of immunosuppressive agents.

Global Tenders stands out as the largest platform dedicated to tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth immunosuppressive agents market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited immunosuppressive agents tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

20 Live Notices for Immunosuppressive Agents Tenders

Showing 1 to 20

Supplies Of Medicinal Products For Drug Programs And Various Drugs
country Poland
posting date28 Nov 2024
deadline30 Dec 2024
Supply Of Medicines With Registration No. 7300011490
country Greece
posting date26 Nov 2024
deadline11 Dec 2024
Supply of RAVULIZUMAB 300MG/3ML INJ
country Oman
posting date26 Nov 2024
deadline02 Dec 2024
Supply of BUPROPION 150 MG XL [ WELLBUTRIN XL ]&USTEKINUMAB 130 MG INJECTION&HEPATITIS B VACCINE 20 MICROGRAM/ML&CITANEST WITH OCTAPRESSIN CARTRIDGES&LAMOTRIGINE-1A PHARMA 50 MG TABLET&EPHEDRINE HYDROCHLORIDE INJ 30 MG&BELATACEPT 250MG INJECTION
country Oman
posting date26 Nov 2024
deadline02 Dec 2024
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date22 Nov 2024
deadline23 Dec 2024
Supplies Of Medicinal Products For Drug Programs And Various Drugs
country Poland
posting date20 Nov 2024
deadline24 Dec 2024
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date19 Nov 2024
deadline19 Dec 2024
Lp Containing Golimumab 2024
country Czech Republic
posting date08 Nov 2024
deadline12 Dec 2024
Medicinal Preparations Containing Golimumab Ii.
country Czech Republic
posting date06 Nov 2024
deadline09 Dec 2024
Lp Containing Ustekinumab 2024
country Czech Republic
posting date06 Nov 2024
deadline11 Dec 2024
Lp Containing Arsenic Oxide 2024
country Czech Republic
posting date06 Nov 2024
deadline11 Dec 2024
Supply Of Medicinal Products And Medical Devices.
country Poland
posting date05 Nov 2024
deadline11 Dec 2024
Supplies Of Medicines – Medicinal Substance Etanercept – Atc L04Ab01
country Czech Republic
posting date05 Nov 2024
deadline04 Dec 2024
Medicinal Products Containing Cladribine And Baricitinib
country Czech Republic
posting date04 Nov 2024
deadline02 Dec 2024
The Medicine Ravulizumab
country Lithuania
posting date15 Oct 2024
deadline15 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
country Germany
posting date10 Nov 2023
deadline27 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
country Germany
posting date14 Aug 2023
deadline28 Jul 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
country Germany
posting date09 Jun 2023
deadline27 May 2025

Share Share this page